Alfred Zippelius Selected Research

Alfred Zippelius Research Topics

Disease

73	Neoplasms (Cancer) 01/2022 - 01/2002
24	Melanoma (Melanoma, Malignant) 11/2019 - 07/2002
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2013
7	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2004
5	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2004
4	Lung Neoplasms (Lung Cancer) 10/2019 - 01/2015
4	Pneumonia (Pneumonitis) 01/2018 - 12/2015
2	Disease Progression 01/2022 - 10/2014
2	Tertiary Lymphoid Structures 01/2021 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2018
2	Carcinogenesis 10/2020 - 10/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2019 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 10/2019
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2017
2	Adenocarcinoma 01/2017 - 05/2016
2	Inflammation (Inflammations) 01/2016 - 11/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 01/2013
1	Hyponatremia 05/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Ovarian Epithelial Carcinoma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 07/2019 - 01/2002
12	AntibodiesIBA 01/2022 - 10/2002
11	Immune Checkpoint InhibitorsIBA 08/2020 - 01/2016
10	Peptides (Polypeptides)IBA 12/2018 - 07/2002
9	Proteins (Proteins, Gene)FDA Link 03/2021 - 09/2004
8	MART-1 AntigenIBA 10/2010 - 07/2002
7	Neoplasm Antigens (Tumor Antigens)IBA 12/2019 - 10/2002
6	LigandsIBA 01/2020 - 10/2010
6	Messenger RNA (mRNA)IBA 12/2019 - 06/2007
6	VaccinesIBA 01/2018 - 01/2002
5	Pharmaceutical PreparationsIBA 01/2021 - 11/2015
5	CytokinesIBA 01/2020 - 02/2016
5	IpilimumabIBA 01/2016 - 01/2015
4	Immunoconjugates (Immunoconjugate)IBA 10/2019 - 08/2014
4	NivolumabIBA 07/2019 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2020
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2022 - 11/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 09/2015
3	EpitopesIBA 03/2009 - 07/2002
3	Differentiation AntigensIBA 02/2007 - 04/2004
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 09/2015
2	Interleukin-2 (IL2)IBA 03/2021 - 10/2010
2	AutoantigensIBA 01/2021 - 05/2003
2	InterferonsIBA 01/2021 - 01/2019
2	Antisense OligonucleotidesIBA 01/2020 - 12/2019
2	Bispecific AntibodiesIBA 12/2019 - 02/2016
2	Blocking AntibodiesIBA 11/2019 - 03/2015
2	Monoclonal AntibodiesIBA 08/2019 - 11/2018
2	carbonic anhydrase XIIIBA 08/2019 - 12/2015
2	pembrolizumabIBA 07/2019 - 01/2015
2	SurvivinIBA 05/2019 - 01/2019
2	Uncoupling Protein 2IBA 04/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 09/2017
2	Ado-Trastuzumab EmtansineIBA 01/2019 - 11/2015
2	RNA (Ribonucleic Acid)IBA 01/2019 - 12/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 04/2004
2	Programmed Cell Death 1 ReceptorIBA 01/2018 - 01/2016
2	PlatinumIBA 01/2018 - 01/2017
2	Pemetrexed (MTA)FDA Link 01/2017 - 09/2015
2	Bevacizumab (Avastin)FDA Link 01/2017 - 09/2015
2	Drug CombinationsIBA 01/2016 - 09/2015
2	VemurafenibIBA 01/2015 - 05/2013
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2010 - 05/2004
2	HLA-A*02:01 antigenIBA 12/2006 - 02/2003
1	Alkaline PhosphataseIBA 05/2022
1	AlbuminsIBA 05/2022
1	MagnesiumIBA 01/2022
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2022
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 10/2021
1	durvalumabIBA 10/2021
1	InterleukinsIBA 03/2021
1	NPI 2358IBA 01/2021
1	CarbohydratesIBA 10/2020
1	LectinsIBA 10/2020
1	HexosaminesIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2020
1	SelectinsIBA 10/2020
1	Polysaccharides (Glycans)IBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Interleukin-13IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 01/2020
1	locked nucleic acidIBA 01/2020
1	KynurenineIBA 01/2020
1	Angiopoietin-2IBA 01/2020
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 01/2020
1	cibisatamabIBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	Adenosine (Adenocard)FDA LinkGeneric 12/2019

Therapy/Procedure

30	Immunotherapy 01/2022 - 01/2002
28	Therapeutics 03/2021 - 08/2003
7	Drug Therapy (Chemotherapy) 10/2021 - 01/2013
6	Radiotherapy 01/2019 - 01/2014
3	Neoadjuvant Therapy 10/2021 - 09/2015